The Australian Veterinary Association (AVA) has been awarded a new grant of USD $125,000 from the Zoetis Foundation to expand ...

Zoetis Inc. closed 23.70% below its 52-week high of $200.33, which the company reached on September 19th.

Zoetis's leadership, scale, and innovation position it well against new competitors. Click here to read more about ZTS stock ...

The stock's fall snapped a three-day winning streak.

Zoetis delivered revenue and adjusted EPS above Wall Street expectations in Q1, driven by strong organic operational growth across its diverse portfolio. Management pointed to particularly robust ...

Investing in attractive dividend growth stocks can lead to superior long-term returns. The two healthcare companies below ...

Each stock has a return on invested capital between 17% and 27%, showing a strong ability to reinvest in their businesses ...

Review Zoetis Inc Class A (ZTS:XNYS) stock and the current sustainability and ESG risk rating to help with your investing decisions.

Animal health company Zoetis (NYSE:ZTS) in Q4 CY2024, with sales up 4.7% year on year to $2.32 billion. On the other hand, the company’s full-year revenue guidance of $9.3 billion at the ...

Animal health company Zoetis (NYSE:ZTS) reported Q1 CY2025 results , with sales up 1.4% year on year to $2.22 billion. The company’s full-year revenue guidance of $9.5 billion at the midpoint ...

Zoetis, a leading animal health company, has shown impressive growth with a 17.55% CAGR since its IPO. Read why I rate ZTS stock a Buy now.

U.S. equities rose at midday ahead of the latest announcement from the Federal Reserve, as President Donald Trump again ...